MedWatch training course
This article was originally published in The Tan Sheet
Executive Summary
FDA has launched an online training seminar on MedWatch and patient safety aimed at health care professional students, practitioners and consumers, the agency announces Jan. 30. The course outlines the agency's role in post-marketing safety surveillance for medical products, describes the reporting to MedWatch, discusses how reports are used by FDA and identifies ways MedWatch disseminates safety information about medical products, FDA states. As part of the recently enacted Dietary Supplement and Nonprescription Drug Consumer Protection Act, adverse events for supplements and monographed OTCs must be submitted using the MedWatch form (1"The Tan Sheet," Dec. 18, 2006, p. 4)...
You may also be interested in...
Adverse Event Collection Expected To Be In Force By Christmas 2007
Firms that make, pack or distribute dietary supplements and over-the-counter drugs approved under monographs will likely have to be in compliance with a new adverse event reporting law by late December 2007
More Heartmate Troubles For Abbott. Latest Recall Includes 14 Deaths
Abbott initiated a recall in February of thousands of Heartmate devices due to a system obstruction that can result in serious health outcomes, including death. The FDA has now designated the recall as class I.
‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs
As it stands, drugmakers will have just 90 days to prepare their dossiers for EU-wide joint clinical assessments under the new Health Technology Assessment Regulation. Market access experts from EFPIA tell the Pink Sheet that this short deadline could delay patient access to complex medicines, such as innovative cancer drugs.